Literature DB >> 22438314

Cluster cytometry for high-capacity bioanalysis.

Bruce S Edwards1, Jingshu Zhu, Jun Chen, Mark B Carter, David M Thal, John J G Tesmer, Steven W Graves, Larry A Sklar.   

Abstract

Flow cytometry specializes in high-content measurements of cells and particles in suspension. Having long excelled in analytical throughput of single cells and particles, only recently with the advent of HyperCyt sampling technology, flow cytometry's multiexperiment throughput has begun to approach the point of practicality for efficiently analyzing hundreds-of-thousands of samples, the realm of high-throughput screening (HTS). To extend performance and automation compatibility, we built a HyperCyt-linked Cluster Cytometer platform, a network of flow cytometers for analyzing samples displayed in high-density, 1,536-well plate format. To assess the performance, we used cell- and microsphere-based HTS assays that had been well characterized in the previous studies. Experiments addressed important technical issues: challenges of small wells (assay volumes 10 μL or less, reagent mixing, cell and particle suspension), detecting and correcting for differences in performance of individual flow cytometers, and the ability to reanalyze a plate in the event of problems encountered during the primary analysis. Boosting sample throughput an additional fourfold, this platform is uniquely positioned to synergize with expanding suspension array and cell barcoding technologies in which as many as 100 experiments are performed in a single well or sample. As high-performance flow cytometers shrink in cost and size, cluster cytometry promises to become a practical, productive approach for HTS, and other large-scale investigations of biological complexity.
Copyright © 2012 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Year:  2012        PMID: 22438314      PMCID: PMC3331957          DOI: 10.1002/cyto.a.22039

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  29 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Suspension array technology: evolution of the flat-array paradigm.

Authors:  John P Nolan; Larry A Sklar
Journal:  Trends Biotechnol       Date:  2002-01       Impact factor: 19.536

3.  High-throughput microfluidic mixing and multiparametric cell sorting for bioactive compound screening.

Authors:  Susan M Young; Mark S Curry; John T Ransom; Juan A Ballesteros; Eric R Prossnitz; Larry A Sklar; Bruce S Edwards
Journal:  J Biomol Screen       Date:  2004-03

4.  Duplexed, bead-based competitive assay for inhibitors of protein kinases.

Authors:  Peter C Simons; Susan M Young; Veronica Gibaja; Wen-Cherng Lee; Serene Josiah; Bruce S Edwards; Larry A Sklar
Journal:  Cytometry A       Date:  2007-07       Impact factor: 4.355

5.  Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes.

Authors:  Susan M Young; Cristian M Bologa; Dan Fara; Bj K Bryant; Juan Jacob Strouse; Jeffrey B Arterburn; Richard D Ye; Tudor I Oprea; Eric R Prossnitz; Larry A Sklar; Bruce S Edwards
Journal:  Cytometry A       Date:  2009-03       Impact factor: 4.355

6.  High-throughput cytotoxicity screening by propidium iodide staining.

Authors:  Bruce S Edwards; Irena Ivnitski-Steele; Susan M Young; Virginia M Salas; Larry A Sklar
Journal:  Curr Protoc Cytom       Date:  2007-07

7.  High-throughput screen for the chemical inhibitors of antiapoptotic bcl-2 family proteins by multiplex flow cytometry.

Authors:  Ramona F Curpan; Peter C Simons; Dayong Zhai; Susan M Young; Mark B Carter; Cristian G Bologa; Tudor I Oprea; Arnold C Satterthwait; John C Reed; Bruce S Edwards; Larry A Sklar
Journal:  Assay Drug Dev Technol       Date:  2011-05-11       Impact factor: 1.738

8.  A multifunctional androgen receptor screening assay using the high-throughput Hypercyt flow cytometry system.

Authors:  Megan K Dennis; Harmony J C Bowles; Debra A MacKenzie; Scott W Burchiel; Bruce S Edwards; Larry A Sklar; Eric R Prossnitz; Todd A Thompson
Journal:  Cytometry A       Date:  2008-05       Impact factor: 4.355

9.  High-content screening: flow cytometry analysis.

Authors:  Bruce S Edwards; Susan M Young; Irena Ivnitsky-Steele; Richard D Ye; Eric R Prossnitz; Larry A Sklar
Journal:  Methods Mol Biol       Date:  2009

10.  High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent.

Authors:  Stuart S Winter; Debbie M Lovato; Hadya M Khawaja; Bruce S Edwards; Irena D Steele; Susan M Young; Tudor I Oprea; Larry A Sklar; Richard S Larson
Journal:  J Biomol Screen       Date:  2008-02-29
View more
  7 in total

1.  The University of New Mexico Center for Molecular Discovery.

Authors:  Bruce S Edwards; Kristine Gouveia; Tudor I Oprea; Larry A Sklar
Journal:  Comb Chem High Throughput Screen       Date:  2014-03       Impact factor: 1.339

Review 2.  The role of HTS in drug discovery at the University of Michigan.

Authors:  Martha J Larsen; Scott D Larsen; Andrew Fribley; Jolanta Grembecka; Kristoff Homan; Anna Mapp; Andrew Haak; Zaneta Nikolovska-Coleska; Jeanne A Stuckey; Duxin Sun; David H Sherman
Journal:  Comb Chem High Throughput Screen       Date:  2014-03       Impact factor: 1.339

3.  A high-throughput phenotypic screen of cytotoxic T lymphocyte lytic granule exocytosis reveals candidate immunosuppressants.

Authors:  Ziyan Zhao; Mark K Haynes; Oleg Ursu; Bruce S Edwards; Larry A Sklar; Adam Zweifach
Journal:  J Biomol Screen       Date:  2014-11-07

Review 4.  Flow Cytometry: Impact on Early Drug Discovery.

Authors:  Bruce S Edwards; Larry A Sklar
Journal:  J Biomol Screen       Date:  2015-03-24

Review 5.  Molecular basis for small molecule inhibition of G protein-coupled receptor kinases.

Authors:  Kristoff T Homan; John J G Tesmer
Journal:  ACS Chem Biol       Date:  2014-07-14       Impact factor: 5.100

6.  Detection of Plasma Protease Activity Using Microsphere-Cytometry Assays with E. coli Derived Substrates: VWF Proteolysis by ADAMTS13.

Authors:  Shobhit Gogia; Chi Y Lo; Sriram Neelamegham
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

7.  Paroxetine is a direct inhibitor of g protein-coupled receptor kinase 2 and increases myocardial contractility.

Authors:  David M Thal; Kristoff T Homan; Jun Chen; Emily K Wu; Patricia M Hinkle; Z Maggie Huang; J Kurt Chuprun; Jianliang Song; Erhe Gao; Joseph Y Cheung; Larry A Sklar; Walter J Koch; John J G Tesmer
Journal:  ACS Chem Biol       Date:  2012-08-21       Impact factor: 5.100

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.